Bioaccessibility of PBDEs present in indoor dust: a novel dialysis membrane method with a Tenax TA® absorption sink

[thumbnail of Tenax_CE_PBET_STOTEN_221017_CDC (2).pdf]
Preview
Text - Accepted Version
· Available under License Creative Commons Attribution Non-commercial No Derivatives.
· Please see our End User Agreement before downloading.
| Preview
[thumbnail of Sup_Info_Tenax_CE_PBET_STOTEN_221017_CDC.pdf]
Preview
Text - Accepted Version
· Available under License Creative Commons Attribution Non-commercial No Derivatives.
· Please see our End User Agreement before downloading.
| Preview

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Kademoglou, K., Williams, A. C. orcid id iconORCID: https://orcid.org/0000-0003-3654-7916 and Collins, C. D. (2018) Bioaccessibility of PBDEs present in indoor dust: a novel dialysis membrane method with a Tenax TA® absorption sink. Science of the Total Environment, 621. pp. 1-8. ISSN 0048-9697 doi: 10.1016/j.scitotenv.2017.11.097

Abstract/Summary

Human uptake of flame retardants (FRs) such as polybrominated diphenyl ethers (PBDEs) via indoor dust ingestion is commonly considered as 100% bioaccessible, leading to potential risk overestimation. Here, we present a novel in vitro colon-extended physiologically-based extraction test (CE-PBET) with Tenax TA® as an absorptive "sink" capable to enhance PBDE gut bioaccessibility. A cellulose-based dialysis membrane (MW cut-off 3.5kDa) with high pH and temperature tolerance was used to encapsulate Tenax TA®, facilitating efficient physical separation between the absorbent and the dust, while minimizing re-absorption of the ingested PBDEs to the dust particles. As a proof of concept, PBDE-spiked indoor dust samples (n=3) were tested under four different conditions; without any Tenax TA® addition (control) and with three different Tenax TA® loadings (i.e. 0.25, 0.5 or 0.75g). Our results show that in order to maintain a constant sorptive gradient for the low MW PBDEs, 0.5g of Tenax TA® are required in CE-PBET. Tenax TA® inclusion (0.5g) resulted in 40% gut bioaccessibility for BDE153 and BDE183, whereas greater bioaccessibility values were seen for less hydrophobic PBDEs such as BDE28 and BDE47 (~60%). When tested using SRM 2585 (n=3), our new Tenax TA® method did not present any statistically significant effect (p>0.05) between non-spiked and PBDE-spiked SRM 2585 treatments. Our study describes an efficient method where due to the sophisticated design, Tenax TA® recovery and subsequent bioaccessibility determination can be simply and reliably achieved.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/74332
Identification Number/DOI 10.1016/j.scitotenv.2017.11.097
Refereed Yes
Divisions Science > School of Archaeology, Geography and Environmental Science > Department of Geography and Environmental Science
Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmaceutics Research Group
Uncontrolled Keywords Bioaccessibility, Dialysis membrane, Indoor dust, PBDEs, Tenax TA®
Publisher Elsevier
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar